FDA snubs another China-made PD-1 with rejection of Elevar, Hengrui's liver cancer combo
FDA snubs another China-made PD-1 with rejection of Elevar, Hengrui's liver cancer combo aliu Thu, 05/16/2024 - 16:49
FDA snubs another China-made PD-1 with rejection of Elevar, Hengrui's liver cancer combo aliu Thu, 05/16/2024 - 16:49
GSK aims to sell remaining stake in consumer health spinoff Haleon through 385M share offer fkansteiner Thu, 05/16/2024 - 13:45
Former Sandoz exec sentenced to probation in price-fixing case zbecker Thu, 05/16/2024 - 11:17
Fire breaks out at Novo production hub: None injured and construction timelines likely unaffected, company says fkansteiner Thu, 05/16/2024 - 11:11
Bristol Myers’ Breyanzi bags FDA nod to follow CAR-T rivals Gilead, Novartis into follicular lymphoma aliu Thu, 05/16/2024 - 10:40
In Big Pharma's growth rankings, Lilly took top spot from Novo Nordisk in Q1 kdunleavy Thu, 05/16/2024 - 08:14
Teva taps Matthew Shields to oversee manufacturing and supply division amid company revamp jkeenan Thu, 05/16/2024 - 07:46
In Novo pricing probe, Sanders cranks up the heat with dire warning on projected GLP-1 spending zbecker Wed, 05/15/2024 - 17:28
With new partnership, Galapagos takes decentralized CAR-T manufacturing quest nationwide fkansteiner Wed, 05/15/2024 - 17:04